Leveraging T2D as a Development Strategy to Forge a Path in Metabolic Indications

Time: 11:30 am
day: Day Two


  • Investigating the clinical path, regulatory, and market access in type 2 diabetes to indicate a more defined pathway into metabolic diseases
  • From diabetes to NASH: how can type 2 diabetes represent the first steps?
  • Assessing successes and setbacks in clinical strategy and development